TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| State forms public-private pact for paperless medical records push The state is hoping a public-private partnership with an eye on electronic medical records helps its chances in snagging a piece of more than $1 billion in federal stimulus dollars. feeds.bizjournals.com |
Navigating Medicare With Pros A growing number of affluent Americans are turning to their financial advisers for guidance navigating the Medicare maze. online.barrons.com |
Lupus Drug Shows Promising Results Human Genome and GlaxoSmithKline said their experimental drug Benlysta met the goal of a second late-stage study in treating lupus, making it likely to be the first treatment in decades for the hard-to-treat autoimmune disease. online.barrons.com |
PSAs Urge Vaccination Against H1N1 Flu - Video U.S. Department of Health and Human Services and the Ad Council Launch New Nationwide PSA Campaign Urging Vaccination against the H1N1 Flu Virus feedproxy.google.com |
Spectrum Pharma: Additional Trial Not Required On Monday, Spectrum Pharmaceuticals (SPPI) reported that regulators will NOT require the company to conduct yet another trial to study Fusilev® for the treatment of colorectal cancer – the indication which the drug’s supplemental new drug application (sNDA) was initially reviewed by regulators in early October 2009. In order to resubmit the Fusilev sNDA for review, SPPI is required to submit additional data to the FDA. Monday, the company said they expect to fulfill the regulatory requirements by Q3 2010. Following resubmission of the sNDA with the required additional data in Q3 2010, Fusilev could be reviewed again by regulators on or near March 31, 2011.Complete Story » seekingalpha.com |